Ultrasound Based Acoustic Radiation Force Impulse Imaging
- Conditions
- Liver FibrosisLiver Inflammation
- Interventions
- Device: Ultrasound-Based Acoustic Radiation Force Impulse (ARFI)
- Registration Number
- NCT01781208
- Lead Sponsor
- University of Michigan
- Brief Summary
ARFI (Ultrasound-based Acoustic Radiation Force Impulse) will be used during ultrasound guided needle biopsy of the liver of children.
- Detailed Description
A new technique based on ultrasound, known as Acoustic Radiation Force Impulse (ARFI) imaging is performed using standard approved ultrasound machines and transducers. The sound waves or impulses are generated in a different pattern and offer information on the stiffness of the tissue. This new technique will be evaluated for usefulness in diagnosing different liver conditions.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 62
-
18 years of age or younger
-
Scheduled to have a needle biopsy of the liver at
- C.S. Mott Children's Hospital or
- Dept. of Radiology at the Univ. of Michigan Hospital
-
Scheduled to have an abdominal ultrasound to evaluate your liver (with no known liver disease)
- None to list
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Ultrasound-based Acoustic Radiation Force Imaging Ultrasound-Based Acoustic Radiation Force Impulse (ARFI) The liver was scanned using ultrasound and ultrasound-based acoustic radiation force impulse imaging technique (ARFI).
- Primary Outcome Measures
Name Time Method ARFI/VTQ and ARFI/VTIQ Liver Shear Wave Speed vs. Liver Histologic Fibrosis Score 10 minutes Tissue shear wave speed is positively correlated to a material's/tissue's stiffness and can be noninvasively measured by ultrasound. The relationship between liver shear wave speed and liver histologic fibrosis score were assessed using 2 different ultrasound methods. Liver shear wave speed as obtained using 2 different ultrasound methods served as our primary outcome measures.
Note, the histologic scoring system (Ishak) ranged from 0 to 6, where 0 = no fibrosis and 6 = cirrhosis.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Michigan Hospital
🇺🇸Ann Arbor, Michigan, United States